Astrana Health Inc. (ASTH)
Astrana Health Inc. (ASTH) Stock Price, Analysis & Data
| Cours acheteur | 29.05 |
| Capitalisation boursière | 1.95B |
| Chiffre d’affaires (ttm) | 3.84B |
| Résultat net (ttm) | 40.55M |
| Bêta | 0.90 |
| EPS (ttm) | 0.82 |
| Ratio P/E (ttm) | 48.05 |
| P/E prévisionnel | 11.13 |
| P/B (ttm) | 2.34 |
| P/S (ttm) | 0.51 |
| Earnings Date | Nov 5, 2026 |
| Cours vendeur | 50.32 |
| Volume | 370,450 |
| Volume moy. (20D) | 611,203 |
| Ouverture | 39.71 |
| Clôture précédente | 39.16 |
| Fourchette du jour | 39.13 - 41.00 |
| Intervalle de 52 semaines | 18.08 - 51.60 |
| Analyste | n/a |
| Objectif de prix | n/a |
| Dividendes | n/a |
| Date ex-dividende | n/a |
À propos de ASTH
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care ...
Performance financière
En 2025, le chiffre d’affaires de Astrana Health s’élevait à 3.18B, soit une hausse de 56.39% par rapport aux 2.03B de l’année précédente. Le bénéfice s’élevait à 22.49M, soit une baisse de -47.89%.
États financiersSurprise sur les résultats
Les analystes prévoient un chiffre d’affaires de ... Passer à l’offre supérieure
1 semaine il y a · Simply Wall St.
Astrana Health (ASTH) Stock Sees Modest Fair Value Lift As Analysts Back Integration ProgressAstrana Health now sits on a modestly higher fair value estimate, with the modeled price moving from about US$47.11 to about US$50.13 per share. That shift lines up with analyst commentary that weighs...
